Form 4: National Healthcare Corp. Executive Timothy J. Shelly Granted Stock Options
SEC Form 4 Filing
Timothy J. Shelly, Sr. VP Operations at National Healthcare Corp, reports the grant of stock options.
Summary
- On February 26, 2025, Timothy J. Shelly, Sr. VP Operations at National Healthcare Corp (NHC), filed a Form 4.
- The filing reports the grant of 11,000 stock options on February 24, 2025, at an exercise price of $90.62 per share.
- These options were granted pursuant to the 2020 Omnibus Equity Incentive Plan.
- The options vest ratably over three years, starting February 24, 2026.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. It reflects a standard executive compensation practice, indicating alignment of interests between management and shareholders.
Positives
- The stock option grant aligns executive compensation with company performance, incentivizing value creation for shareholders.
Industry Context
Stock option grants are a common practice in the healthcare industry to incentivize executives and align their interests with those of shareholders.
Comparison to Industry Standards
- Stock option grants are a typical component of executive compensation packages in publicly traded healthcare companies.
- Companies like Brookdale Senior Living and LifePoint Health also utilize stock options as part of their executive compensation plans.
- The vesting schedule of three years is also fairly standard in the industry.
Stakeholder Impact
- Shareholders may view the stock option grant positively as it incentivizes management to improve company performance.
- Employees may see it as a positive sign of the company investing in its leadership.
Key Dates
| Date | Description |
|---|---|
| 02/18/2023 | Date exercisable for existing options with an exercise price of $63.96 |
| 03/08/2024 | Date exercisable for existing options with an exercise price of $53.94 |
| 03/05/2025 | Date exercisable for existing options with an exercise price of $94.1 |
| 02/24/2025 | Date of stock option grant to Timothy J. Shelly |
| 02/24/2026 | First vesting date for the newly granted stock options (1/3 of the options) |
| 02/18/2027 | Expiration date for existing options with an exercise price of $63.96 |
| 02/24/2027 | Second vesting date for the newly granted stock options (1/3 of the options) |
| 03/08/2028 | Expiration date for existing options with an exercise price of $53.94 |
| 02/24/2028 | Final vesting date for the newly granted stock options (1/3 of the options) |
| 03/05/2029 | Expiration date for existing options with an exercise price of $94.1 |
| 02/24/2030 | Expiration date for the newly granted stock options |
| 02/26/2025 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.